secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2025-07-17T23:59:59+00:00
Accession:  0001156039-25-000111
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health cuts FY2025 adjusted EPS guidance to ~$30 on elevated medical costs
--------------------------------------------------------------------------------

- Operating revenue $49.4B (+14.3% YoY); diluted EPS $7.72, adjusted diluted EPS $8.84.
- Benefit expense ratio 88.9% (+260 bps) reflecting higher medical costs in Medicaid and ACA.
- FY2025 GAAP EPS guidance ~$24.10; adjusted EPS guidance ~$30.00 (previously ~$35).
- Health Benefits segment operating gain $1.6B vs $2.1B prior year; margin 3.8% vs 5.8%.
- Returned $2.0B of capital to shareholders YTD; declared $1.71/quarter dividend payable 9/25/25.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603925000111/0001156039-25-000111-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603925000111/elv-20250717.htm
  HTML page:      https://secwatch.observer/filing/0001156039-25-000111

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer